Trinity Biotech

Trinity Biotech was established in 1992 and listed on the NASDAQ market shortly after its formation. The company has amassed a remarkable product portfolio and attained the highest levels of quality in creating, producing, and marketing diagnostic products through a combination of steady, organic expansion and an acquisition-led approach.

Currently, Trinity Biotech has over 21 million American Depository Shares and is listed on the NASDAQ Global Select Market. The company, which has its global headquarters in Bray, Ireland, employs more than 570 people and sells its range of more than 400 goods to clients in more than 110 nations.

Diagnostic test kit research, production, and marketing are Trinity Biotech's areas of expertise. Their organisation continually meets the highest standards of excellence in the calibre of everything they do, which is the foundation of their ongoing success.

They produce test kits that are utilized in the clinical laboratory and point-of-care diagnostic market segments to identify infectious diseases, STDs, autoimmune diseases, hemoglobin abnormalities, and to identify, monitor, and manage diabetes. They also play a sizable role as a raw material supplier to the life sciences sector. Trinity Biotech is one of the largest biotech companies in Ireland.

Founded: 1992

Headquarters: Co Wicklow, Ireland

Website: https://www.trinitybiotech.com/